These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 31556196)
1. MYD88 L265P mutation analysis is a useful diagnostic adjunct for lymphoplasmacytic lymphoma with pleural effusion. Pan ST; Wang RC; Kuo CC; Hsieh YC; Su YZ; Chuang SS Pathol Int; 2019 Oct; 69(10):601-607. PubMed ID: 31556196 [TBL] [Abstract][Full Text] [Related]
2. MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders. Ondrejka SL; Lin JJ; Warden DW; Durkin L; Cook JR; Hsi ED Am J Clin Pathol; 2013 Sep; 140(3):387-94. PubMed ID: 23955458 [TBL] [Abstract][Full Text] [Related]
3. [Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88 Kida T; Tanimura A; Ono A; Matsui T; Honma K; Fujita J; Maeda T; Shibayama H; Oritani K; Morii E; Kanakura Y Rinsho Ketsueki; 2017; 58(2):155-160. PubMed ID: 28321094 [TBL] [Abstract][Full Text] [Related]
4. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report. Barnes M; Sharma P; Kumar V; Kaell A; LiPera W J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665 [TBL] [Abstract][Full Text] [Related]
5. MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity. Schmidt J; Federmann B; Schindler N; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L Br J Haematol; 2015 Jun; 169(6):795-803. PubMed ID: 25819228 [TBL] [Abstract][Full Text] [Related]
7. Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphoma. Capaldi IB; May AM; Schmitt-Graeff A; Follo M; Aumann K; Kayser G; Perazzo JC; Werner M; Fisch P Exp Mol Pathol; 2014 Aug; 97(1):57-65. PubMed ID: 24842316 [TBL] [Abstract][Full Text] [Related]
8. Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature. Bassarova A; Trøen G; Spetalen S; Micci F; Tierens A; Delabie J Am J Clin Pathol; 2015 Jun; 143(6):797-806. PubMed ID: 25972321 [TBL] [Abstract][Full Text] [Related]
9. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316 [TBL] [Abstract][Full Text] [Related]
10. Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma. Burnworth B; Wang Z; Singleton TP; Bennington A; Fritschle W; Bennington R; Brodersen LE; Wells DA; Loken MR; Zehentner BK Leuk Res; 2016 Dec; 51():41-48. PubMed ID: 27890075 [TBL] [Abstract][Full Text] [Related]
11. An unusual case of cutaneous Waldenström macroglobulinemia with the MYD88 L265P mutation. Minzenmayer AN; Miranda RN; Powell PR; Parekh PK J Cutan Pathol; 2020 Sep; 47(9):850-853. PubMed ID: 32335928 [TBL] [Abstract][Full Text] [Related]
12. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations. King RL; Gonsalves WI; Ansell SM; Greipp PT; Frederick LA; Viswanatha DS; He R; Kyle RA; Gertz MA; Kapoor P; Morice WG; Howard MT Am J Clin Pathol; 2016 Jun; 145(6):843-51. PubMed ID: 27329639 [TBL] [Abstract][Full Text] [Related]
14. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation. Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566 [TBL] [Abstract][Full Text] [Related]
15. [Successful diagnosis of lymphoplasmacytic lymphoma with IgG paraprotein using MYD88 L265P mutation analysis]. Abe M; Saburi M; Itani K; Kohno K; Soga Y; Kondo Y; Kawano Y; Nakayama T Rinsho Ketsueki; 2018; 59(6):695-697. PubMed ID: 29973445 [TBL] [Abstract][Full Text] [Related]
16. [The pathology and genetic background of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia]. Timár B Magy Onkol; 2017 Mar; 61(1):6-11. PubMed ID: 28273183 [TBL] [Abstract][Full Text] [Related]
17. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. Martinez-Lopez A; Curiel-Olmo S; Mollejo M; Cereceda L; Martinez N; Montes-Moreno S; Almaraz C; Revert JB; Piris MA Am J Surg Pathol; 2015 May; 39(5):644-51. PubMed ID: 25723115 [TBL] [Abstract][Full Text] [Related]
18. Frequency of MYD88 L256P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasm. Shekhar R; Naseem S; Binota J; Varma N; Malhotra P Hematol Oncol Stem Cell Ther; 2021 Sep; 14(3):231-239. PubMed ID: 33217360 [TBL] [Abstract][Full Text] [Related]
19. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease. Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994 [TBL] [Abstract][Full Text] [Related]
20. MYD88 mutant lymphoplasmacytic lymphoma/Waldenström macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart. Patkar N; Subramanian PG; Deshpande P; Ghodke K; Tembhare P; Mascarenhas R; Muranjan A; Chaudhary S; Bagal B; Gujral S; Sengar M; Menon H Leuk Lymphoma; 2015 Feb; 56(2):420-5. PubMed ID: 24828863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]